Use of methotrexate in patients with psoriatic arthritis

CER4124
2010 Vol.28, N°5 ,Suppl.61
PI 0132, PF 0137
Review

Free to view
(click on article PDF icon to read the article)

PMID: 21044447 [PubMed]

Received: 01/09/2010
Accepted : 01/09/2010
In Press: 28/10/2010
Published: 28/10/2010

Abstract

Despite a paucity of high quality clinical data, methotrexate (MTX) remains one of the most commonly used medications in the treatment of patients with psoriatic arthritis (PsA). This report addresses mechanistic rationale, available clinical evidence, safety considerations, and a potential research agenda regarding the use of MTX in the management of PsA.